Adrenal Cortex Neoplasms - 12 Studies Found

Completed : Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
: Adrenocortical Carcinoma
: 2012-02-05
:
  • Genetic: DNA methylation analysis
  • Genetic:
Active, not recruiting : Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
:
  • Stage I Adrenocortical Carcinoma
  • Stage II Adrenocortical Carcinoma
  • Drug: doxorubicin hydrochloride

Active, not recruiting : Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
:
  • Adrenocortical Carcinoma
  • Peritoneal Carcinomatosis

: 2013-04-12
:
  • Drug: Cisplatin Patients who a
Completed : Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
: Adrenocortical Carcinoma
: 2011-12-21
: Drug: Dovitinib Dovitinib (TKI-258), gelatin capsule of 10
Completed : A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
: Adrenocortical Carcinoma
: 2009-06-17
:
  • Drug: OSI-906 Administered ora
Completed : Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
:
  • Recurrent Adrenocortical Carcinoma
  • Stage III Adrenocortical Carcinoma
  • Drug: Sorafenib Treatment sche
Terminated : IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery
:
  • Recurrent Adrenocortical Carcinoma
  • Stage III Adrenocortical Carcinoma
  • Biological: IMC-A12 Given IV
Recruiting : Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
: Adrenocortical Carcinoma
: 2008-10-21
: Drug: MITOTANE mitotane will be administered at a starting dose of 1.5 g/day and increased in case of go
Withdrawn : Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
: Adrenocortical Carcinoma
: 2007-05-02
: Drug: Bevacizumab
Next >>>